Zentek (ZTEK) Stock Price, News & Analysis

Company Overview

Zentek Ltd. (NASDAQ: ZTEK) is a Canadian nanotechnology company that develops and commercializes advanced materials and technology solutions. Its work is centered on graphene and other nanomaterials, with applications in healthcare, air filtration, surface protection and industrial products.

The company’s product portfolio has included ZENGuard, an antimicrobial coating designed for use in protective equipment and air-filtration systems. Zentek has also developed graphene-enhanced filtration products and technologies intended to improve the capture and inactivation of airborne contaminants. In addition, the company is pursuing applications involving ice-phobic and corrosion-resistant coatings, as well as biomedical technologies such as aptamer-based detection platforms.

Zentek is headquartered in Canada and has historically focused on developing technologies for domestic and international markets through commercialization partners, licensing arrangements and product sales. The company was previously known as ZEN Graphene Solutions and adopted the Zentek name as it expanded beyond its original graphene-resource focus. Its activities have included the evaluation and development of the Albany Graphite deposit in Ontario, although its current business strategy emphasizes technology commercialization.

The company has been led by Greg Fenton as chief executive officer, alongside a management and technical team focused on nanomaterials, product development and commercialization.

Key Stats

• Today's Range: $0.49 to $0.49
• 50-Day Range: $0.49 to $0.68
• 52-Week Range: $0.37 to $1.24
• Volume: N/A
• Average Volume: 224,099 shs
• Market Capitalization: $62.30 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Zentek Stock Analysis - MarketRank™

Zentek scored higher than 0% of companies evaluated by MarketBeat, and ranked 594th out of 594 stocks in the technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.5 / 5
• Analyst Rating: Sell

Consensus Rating

Zentek has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Zentek has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Zentek is -7.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Zentek is -7.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Zentek has a P/B Ratio of 3.51. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for ZTEK.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Zentek does not currently pay a dividend.

Dividend Growth

Zentek does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

1 people have searched for ZTEK on MarketBeat in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Zentek insiders have not sold or bought any company stock.

Percentage Held by Institutions

0.77% of the stock of Zentek is held by institutions.

Company Calendar

• Last Earnings: 8/14/2026
• Today: 10/18/2026
• Next Earnings (Estimated): 11/12/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Technology
• Industry: IT Services
• Sub-Industry: N/A
• Current Symbol: NASDAQ:ZTEK
• CIK: 1904501
• Web: www.zentek.com
• Phone: (844) 730-9822
• Fax: 416-595-8695
• Employees: 24
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.07)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$7.07 million
• Net Margins: -5,848.76%
• Pretax Margin: -9,570.89%
• Return on Equity: -70.93%
• Return on Assets: -52.26%

Debt

• Debt-to-Equity Ratio: 0.07
• Current Ratio: 4.65
• Quick Ratio: 4.54

Sales & Book Value

• Annual Sales: $108.25 thousand
• Price / Sales: 575.49
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.14 per share
• Price / Book: 3.51

Miscellaneous

• Outstanding Shares: 126,620,000
• Free Float: N/A
• Market Cap: $62.30 million
• Optionable: Not Optionable
• Beta: 0.40